Piper Jaffray Raises Price Target on Cepheid Stock

The bank raised its price target on Cepheid's stock from $33 to $38 and upped its revenues and EPS estimates for 2012.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories